業(yè)執(zhí)照.jpg)
莪術(shù)醇
分析標(biāo)準(zhǔn)品,HPLC≥98%
Curcumol
CAS號(hào)：4871-97-0
分子式：C15H24O2
分子量：236.35
MDL：MFCD00272163
貨號(hào) | 規(guī)格/參數(shù)/品牌 | 價(jià)格 | 貨期 |
YJ-B20342-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥300.00 | 現(xiàn)貨 |
YJ-B20342-200mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥840.00 | 現(xiàn)貨 |
YJ-B20342-600mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1700.00 | 現(xiàn)貨 |
A10121-20mg | 分析標(biāo)準(zhǔn)品,含量99.0%，可溯源 | ￥350.00 | 現(xiàn)貨 |
JT98438-1ml買(mǎi)5贈(zèng)1 | 10mM in DMSO | ￥608.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點(diǎn)：141-142℃
沸點(diǎn)：334.5 ℃ at 760 mmHg
比旋光度：(c, 2.127 in CHCl3)-32.26
外觀：無(wú)色針狀結(jié)晶（乙酸乙酯）
溶解性：易溶于氯仿、乙mi，溶于乙醇，微溶于石油醚，幾乎不溶于水。
儲(chǔ)存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶(hù)參考交流研究之用。
參考文獻(xiàn)(28篇)
28. [IF=3.8] Xu Wang et al."A HPLC-assisted mathematical prediction method of ternary solvent systems to develop an intelligent online selection system for countercurrent chromatography solvent system."JOURNAL OF CHROMATOGRAPHY A.2024 Dec;:465585
27. [IF=4.8] Yixin Yao et al."Exploring the quality marker of Curcumae kwangsiensis radix from different production regions using the spectrum-effect relationship, serum metabolism, and molecular docking integrated with chemometrics."JOURNAL OF ETHNOPHARMACOLOGY.2025
26. [IF=4.9] Yi Zhang et al."Transnasal PLGA Nanoparticles with Terpene Permeation Enhancers: Membrane Remodeling and Tight Junction Modulation for Enhanced Brain Drug Delivery."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2025 Apr;26(8):3861
25. [IF=8.5] Wenlong Wei et al."A novel and practical strategy for comprehensive differentiation and profiling of eight Curcumae varieties and their counterfeit from the Chinese market."FOOD CHEMISTRY.2025 Jan;:142842
24. [IF=2.5] Dahai Hou et al."Curcumol Promotes Immune Cell Invasion and Angiogenesis in Colon Cancer by Decreasing IGF2BP3 Expression."BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS.2025 Jan;:151394
23. [IF=6.7] Yu Li et al."The processing mechanism of Vinegar-processed Curcumae Rhizome enhances anti hepatic fibrotic effects through regulation of PI3K/Akt/mTOR signaling pathway."PHYTOMEDICINE.2024 Sep;:156098
22. [IF=3.3] Wuxia Zhao et al."Curcumol promotes ferroptosis of colon cancer by targeting the ubiquitination and degradation of GPX4."Journal of Traditional and Complementary Medicine.2024 Aug;:
21. [IF=7.3] Xin-yi Wang et al."CwJAZ4/9 negatively regulates jasmonate-mediated biosynthesis of terpenoids through interacting with CwMYC2 and confers salt tolerance in Curcuma wenyujin."PLANT CELL AND ENVIRONMENT".2024 Apr;:
20. [IF=5.4] Jialing Sun et al."Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology."JOURNAL OF ETHNOPHARMACOLOGY".2024 Feb;:117985
19. [IF=4.8] Bian-Xia Xue et al."A strategy integrating GC–MS, UPLC profiling, and DNA metabarcoding for characterization and discrimination of the medicinal and culinary pieces from four Curcuma species."MICROCHEMICAL JOURNAL".2024 Aug;203:110895
18. [IF=5.4] Suyan Liu et al."In vitro inhibition of six active sesquiterpenoids in zedoary turmeric oil on human liver cytochrome P450 enzymes."JOURNAL OF ETHNOPHARMACOLOGY.2024 Mar;322:117588
17. [IF=5.8] Xu Wenjing et al."Icariin-Curcumol promotes docetaxel sensitivity in prostate cancer through modulation of the PI3K-Akt signaling pathway and the Warburg effect."Cancer Cell International.10.1186/s12935-023-03042-1
16. [IF=5.9] Cheng-xi Jiang et al."Integrative omic and transgenic analyses reveal methyl jasmonate- and abscisic acid-responsive regulator CwbHLH2 that positively regulates terpenoid biosynthesis in Curcuma wenyujin."INDUSTRIAL CROPS AND PRODUCTS.2024 Mar;209:118039
15. [IF=5.195] Yong-Hui Yu et al."Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway."JOURNAL OF ETHNOPHARMACOLOGY.2023 Mar;:116311
14. [IF=6.438] Wenjing Xu et al."Effects of icariin and curcumol on autophagy, ferroptosis, and lipid metabolism based on miR-7/m-TOR/SREBP1 pathway on prostate cancer."BIOFACTORS.2022 Dec;:
13. [IF=2.65] Sheng Wen et al."Curcumol Inhibits the Development of Prostate Cancer by miR-125a/STAT3 Axis."Evidence-based Complementary and Alternative Medicine.2022;2022:9317402
12. [IF=7.658] Mingyue Zhou et al."Atomic zinc sites with hierarchical porous carbon for high-throughput chemical screening with high loading capacity and stability."Pharmacol Res. 2022 Mar;:106154
11. [IF=3.906] Wen Sheng et al."Curcumol inhibits the malignant progression of prostate cancer and regulates the PDK1/AKT/mTOR pathway by targeting miR?9."Oncol Rep. 2021 Nov;46(5):1-11
10. [IF=2.727] Shen Song et al."Spectrum-effect relationship analysis by binary chromatographic fingerprint to identify components responsible for the antibacterial activity of the essential oil from Curcumae wenyujin."Int J Food Prop. 2018;21(1):546-556
9. [IF=5.64] Wu Dousheng et al."Oleanolic Acid Induces the Type III Secretion System of Ralstonia solanacearum."Front Microbiol. 2015 Dec;0:1466
8. 張曉云,崔小兵,何瑞欣,王琪,徐雅蝶,嵇晶,李秋桐,曹杰,唐婷婷,房雨彤,程建明.基于指紋圖譜及化學(xué)模式識(shí)別方法優(yōu)選經(jīng)典名方溫經(jīng)湯中莪術(shù)藥材產(chǎn)地[J].遼寧中醫(yī)藥大學(xué)學(xué)報(bào),2021,23(01):35-39.
7. 馮藜櫪, 曹文富, 葉鳳. 莪術(shù)含藥血清抑制大鼠HSC中Glil和β-catenin表達(dá)的機(jī)制研究[J]. 重慶醫(yī)科大學(xué)學(xué)報(bào), 2017, 042(003):308-314.
6. 洪宗超, 吳和珍, 楊艷芳,等. 基于GC-MS及GC技術(shù)對(duì)片姜黃揮發(fā)油成分的定性定量分析[J]. 中南藥學(xué), 2019, 17(03):112-120.
5. 郝敏 陸兔林 毛春芹 等. 3種溫郁金根莖炮制品的UPLC指紋圖譜與多成分含量測(cè)定研究[J]. 中國(guó)中藥雜志 2018 43(11).
4. 周微, 韓景蘭, 李太紅. 莪術(shù)醇對(duì)非小細(xì)胞肺癌A549細(xì)胞侵襲,遷移及上皮間質(zhì)轉(zhuǎn)化的影響[J]. 中醫(yī)學(xué)報(bào), 2019, 34(008):1675-1680.
3. 王風(fēng)云, 李偉宏. 莪術(shù)醇固體脂質(zhì)納米粒的制備及其抗腫瘤活性[J]. 中成藥, 2020, 042(005):1114-1119.
2. 王卯, 葉麗紅. 芪竹方中單體及配伍對(duì)人胃癌細(xì)胞MGC-803抑制作用研究[J]. 中醫(yī)藥學(xué)報(bào), 2012, 40(004):26-28.
1. 潘春林, 范恒. 姜黃揮發(fā)油成分氣相指紋圖譜研究.
從2011年開(kāi)始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實(shí)驗(yàn)技術(shù)及論文潤(rùn)色服務(wù)，協(xié)助客戶(hù)各類(lèi)實(shí)驗(yàn)服務(wù)及論文潤(rùn)色十余年，是客戶(hù)您值得信賴(lài)的科研合作伙伴!
如果您受時(shí)間、試驗(yàn)條件等限制而無(wú)法完成您的課題研究，歡迎您與我們聯(lián)系。
實(shí)驗(yàn)技術(shù)服務(wù)：
